19 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35020256 | Charge Matters: Mutations in Omicron Variant Favor Binding to Cells. | 2022 Mar 18 | 1 |
2 | 35054983 | Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant's Superior Transmission. | 2022 Jan 12 | 2 |
3 | 35060381 | Structural Insights into the Cofactor Role of Heparin/Heparan Sulfate in Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II. | 2022 Feb 14 | 2 |
4 | 35169535 | Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants. | 2022 Feb 11 | 1 |
5 | 35269476 | The Future of the COVID-19 Pandemic: How Good (or Bad) Can the SARS-CoV2 Spike Protein Get? | 2022 Mar 2 | 1 |
6 | 35440680 | Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection. | 2022 Apr 15 | 5 |
7 | 33514685 | Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection. | 2021 Jan 29 | 1 |
8 | 33791697 | The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection. | 2021 Mar 26 | 2 |
9 | 33915212 | Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy. | 2021 Jul 31 | 1 |
10 | 33968333 | Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain. | 2021 | 2 |
11 | 34013835 | Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate. | 2021 Dec | 3 |
12 | 34179075 | Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer. | 2021 | 2 |
13 | 34200372 | ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin. | 2021 Jun 7 | 1 |
14 | 34235261 | Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2. | 2021 Jun 23 | 2 |
15 | 34356644 | COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? | 2021 Jul 13 | 1 |
16 | 34743814 | SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate. | 2021 Dec 15 | 3 |
17 | 32699853 | SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. | 2020 Jul 14 | 4 |
18 | 32970989 | SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. | 2020 Nov 12 | 3 |
19 | 33298900 | Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro. | 2020 Nov 4 | 4 |